Vancouver, BC, March 7, 2016 - Segra Biogenesis Corp is pleased to announce that the Company has successfully navigated its second natural product from development to approval, having been issued a natural product number from Health Canada. Skullcap Serenity is a safe and effective natural anti-anxiety product, with clinically demonstrated ability to reduce symptoms of anxiety. Anxiety disorders are the most common mental illness in the U.S., affecting 40 million adults in the United States age 18 and older, or 18% of the population. Anxiety disorders are highly treatable, yet only about one-third of those suffering receive treatment.

Skullcap Serenity is the second of many natural products Segra has developed using its natural product development system. This method, designed by the Company's scientific team, enables the Company to develop natural products from conception to market, efficiently. At Segra, we believe in only basing our products claims for efficacy and safety on validated scientific research, and in being transparent about the sources of the research with our customers. For more information on Skullcap Serenity including peer reviewed publications visit http://segra-intl.com/anxiety-disorders/

Segra Biogenesis Corp. is an emerging specialist Research and Development Company focused on plantbased medicines, including medicinal cannabis. Our team is driven by its experience in research and development work in medicine, genetics, cultivation techniques, natural medicines, biochemistry, agriculture and information technology. Segra's goal is to research, develop, test and produce very unique and specific cultivars from the plant kingdom that are effective for specific ailments in medical patients.

Segra Biogenesis Corp
www.segra-intl.com

For Information Contact:
Todd McMurray
President
Email:todd@segra-intl.com

‍